Sakar Healthcare Limited

307.9

INR
-1.30(-0.42%)
As of November 14, 2024 10:00:00 AM

Sakar Healthcare Limited Share Price Information

24 hour Low and High

Low: 307.05
High: 312.9

All time High

442.05

Price Change 1h

+₹-1.30 +-0.42%

Price Change 1d

+₹-1.30 +-0.42%

Price Change 1w

+₹-6.85 +-2.18%

Sakar Healthcare Limited Market Information

Exchange

NSE

Market Cap

527.06 Cr

About Sakar Healthcare Limited Share

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

325

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Sakar Healthcare soars after oncology unit receives EU GMP approval
  • Sakar Healthcare's Stock Reaches All-Time High, Outperforms Market with Strong Pharmaceutical Presence
  • Sakar Healthcar Consolidated September 2024 Net Sales at Rs 42.78 crore, up 25.53% Y-o-Y
  • Stock Market Highlights: Tech View: Nifty charts hint at indecisiveness; key hurdle at 24,400. Here’s how...
  • Sakar Healthcare's Stock Reaches All-Time High, Outperforms Sector and Sensex

FAQs

Sakar Healthcare Limited

307.9

INR
-1.30(-0.42%)
As of November 14, 2024 10:00:00 AM

Sakar Healthcare Limited Share Price Information

24 hour Low and High

Low: 307.05
High: 312.9

All time High

442.05

Price Change 1h

+₹-1.30 +-0.42%

Price Change 1d

+₹-1.30 +-0.42%

Price Change 1w

+₹-6.85 +-2.18%

Sakar Healthcare Limited Market Information

Exchange

NSE

Market Cap

527.06 Cr

About Sakar Healthcare Limited Share

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

325

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Sakar Healthcare soars after oncology unit receives EU GMP approval
  • Sakar Healthcare's Stock Reaches All-Time High, Outperforms Market with Strong Pharmaceutical Presence
  • Sakar Healthcar Consolidated September 2024 Net Sales at Rs 42.78 crore, up 25.53% Y-o-Y
  • Stock Market Highlights: Tech View: Nifty charts hint at indecisiveness; key hurdle at 24,400. Here’s how...
  • Sakar Healthcare's Stock Reaches All-Time High, Outperforms Sector and Sensex

FAQs